REGENXBIO的动态

查看REGENXBIO的公司主页,图片

33,667 位关注者

Today, we announced that we will be hosting a webcast to discuss our AFFINITY DUCHENNE pivotal program and new clinical data, including the first functional data from the ongoing Phase I/II study of RGX-202 for the treatment of Duchenne. Learn more: https://lnkd.in/eJNrBekb

  • text
Deborah Standafer

Exceptionally effective and personable Clinical Trials Leader

2 天前

sorry I missed this! I will look for the results. best, Deborah S.

回复

要查看或添加评论,请登录